Billions Co.,Ltd. (KOSDAQ:044480)
South Korea · Delayed Price · Currency is KRW 2,860.00
+85.00 (3.06%)
At close: Oct 23, 2026
Billions Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 25,310 | 25,310 | 41,725 | 28,987 | 70,649 | 25,764 |
Revenue Growth | -39.34% | -39.34% | 43.94% | -58.97% | 174.22% | 97.43% |
Gross Profit Gross Profit Growth | 4,944 | 4,944 | 6,235 | 5,684 | 19,115 | 3,654 |
Operating Income Operating Income Growth | -1,760 | -1,760 | -2,819 | -612.59 | -2,993 | -6,573 |
Net Income Net Income Growth | -7,134 | -7,134 | -1,964 | -13,813 | -18,864 | -29,489 |
Earnings Per Share EPS Growth | -3382.96 | -3382.96 | -1276.77 | -37325.38 | -14580.66 | -27665.28 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Medical Device Manufacturing and Sales Division Medical Device Manufacturing and Sales Division Growth | 10,144 | 10,144 | 10,584 | 13,028 |
Management Division Management Division Growth | 15,166 | 15,166 | 17,217 | 4,633 |
Video Production and Distribution Division Video Production and Distribution Division Growth | - | - | 13,924 | 7,266 |
Total Total Growth | 25,310 | 25,310 | 41,725 | 28,987 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,284 | 13,284 | 5,957 | 40,078 | 49,170 | 34,594 |
Total Debt Total Debt Growth | 15,136 | 15,136 | 16,787 | 68,797 | 46,262 | 51,898 |
Net Cash (Debt) Net Cash Growth | -1,852 | -1,852 | -10,831 | -28,718 | 2,908 | -17,304 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -878.14 | -878.14 | -5956.79 | -21561.43 | 2247.84 | -16233.81 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 721.55 | 721.55 | 677.4 | -3,363 | -1,641 | -2,014 |
Capital Expenditures CapEx Growth | -80.76 | -80.76 | -5,198 | -17,658 | -5,635 | -22,180 |
Free Cash Flow Free Cash Flow Growth | 640.78 | 640.78 | -4,521 | -21,021 | -7,276 | -24,194 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.53% | 19.53% | 14.94% | 19.61% | 27.06% | 14.18% |
Operating Margin | -6.95% | -6.95% | -6.76% | -2.11% | -4.24% | -25.51% |
Pretax Margin | -29.37% | -29.37% | -4.68% | 8.27% | -6.21% | -123.57% |
Profit Margin | -28.19% | -28.19% | -4.71% | -47.65% | -26.70% | -114.46% |
FCF Margin | 2.53% | 2.53% | -10.83% | -72.52% | -10.30% | -93.91% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | 29.68 | 37.26 | - | - | - | - |
PS Ratio | 0.75 | 0.94 | 0.46 | 1.33 | 0.68 | 5.10 |